Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Delayed
Japan Exchange
07:44:42 10/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 6,613.00 JPY | -0.90% |
|
+0.38% | +36.77% |
| Market Cap | 10,660B 67.45B 60.2B 55.4B 50.28B 95.28B 6,322B 97.65B 663B 264B 3,385B 253B 248B | P/E 2027 * |
48.3x | P/E 2028 * | 33.2x |
|---|---|---|---|---|---|
| Enterprise Value | 14,613B 92.46B 82.53B 75.94B 68.92B 131B 8,667B 134B 908B 362B 4,640B 347B 340B | EV / Sales 2027 * |
3.11x | EV / Sales 2028 * | 2.99x |
| Free-Float |
99.18% | Yield 2027 * |
3.06% | Yield 2028 * | 3.12% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
Tradegate
| TKD | Real-time | |
|
Börse Stuttgart
| TKD | Delayed | |
|
Boerse Muenchen
| TKD | Real-time | |
|
OTC Markets
| TKPHF | Delayed | |
|
Sapporo S.E.
| 4502 | Delayed | |
|
Deutsche Boerse AG
| TKD | Delayed | |
|
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -0.90% | ||
| 1 week | +0.38% | ||
| Current month | -0.57% | ||
| 1 month | +10.90% | ||
| 3 months | +18.47% | ||
| 6 months | +28.11% | ||
| Current year | +36.77% |
| 1 week | 6,490 |  | 6,989 |
| 1 month | 5,824 | | 6,989 |
| Current year | 4,710 | | 6,989 |
| 1 year | 4,191 | | 6,989 |
| 3 years | 3,852 | | 6,989 |
| 5 years | 2,993 | | 6,989 |
| 10 years | 2,894.5 | | 6,989 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 61 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/4/26 A | Sell | Executive/Senior Manager | -55,617 | 0.0035% | ||
| 11/2/26 A | Sell | Executive/Senior Manager | -46,609 | 0.0029% | ||
| 9/14/26 A | Sell | Executive/Senior Manager | -34,535 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | +0.38% | +58.13% | +59.23% | 66.18B | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,206B | |
| +2.13% | +4.27% | +51.21% | +91.36% | 665B | |
| +0.68% | +1.54% | +33.83% | +112.47% | 515B | |
| +2.77% | +0.98% | +49.44% | +68.46% | 381B | |
| +1.38% | +0.27% | +72.42% | +45.30% | 362B | |
| +0.29% | +1.48% | +30.84% | +58.32% | 307B | |
| +0.98% | +1.49% | +9.04% | +34.78% | 289B | |
| +1.04% | -0.05% | +45.29% | +76.18% | 249B | |
| +1.46% | -0.59% | +42.48% | +125.82% | 207B | |
| Average | +1.45% | +0.19% | +44.54% | +81.07% | 425B | |
| Weighted average by Cap. | +2.25% | +0.62% | +46.18% | +95.47% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,706B 29.78B 26.58B 24.46B 22.2B 42.06B 2,791B 43.11B 293B 117B 1,494B 112B 109B | 4,813B 30.46B 27.18B 25.01B 22.7B 43.02B 2,855B 44.09B 299B 119B 1,528B 114B 112B |
| Net income | 209B 1.32B 1.18B 1.09B 986M 1.87B 124B 1.91B 12.99B 5.18B 66.36B 4.96B 4.86B | 338B 2.14B 1.91B 1.76B 1.59B 3.02B 200B 3.09B 21B 8.37B 107B 8.02B 7.85B |
| Net Debt | 3,954B 25.01B 22.33B 20.55B 18.65B 35.34B 2,345B 36.22B 246B 97.96B 1,255B 93.89B 91.88B | 3,727B 23.58B 21.05B 19.37B 17.58B 33.31B 2,210B 34.14B 232B 92.34B 1,183B 88.5B 86.61B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/11/26 | ¥6,613.00 | -0.90% | 1,617,900 |
| 09/11/26 | ¥6,673.00 | +1.72% | 4,942,800 |
| 06/11/26 | ¥6,560.00 | -4.76% | 8,017,200 |
| 05/11/26 | ¥6,888.00 | +4.55% | 6,566,200 |
| 04/11/26 | ¥6,588.00 | -0.89% | 5,892,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
